TRAF2 and diffuse large B-cell lymphoma: Moreover, functional genetic screens in DLBCL cell lines identified TRAF2 as a factor conferring resistance against mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor and the cereblon E3 ligase–modulating agent CC-122 [229,230].